Izotropic (FRA:1R3) Research & Development: €0.48 Mil (TTM As of Jan. 2026)


FRA:1R3 Izotropic Corp FRA:1R3
28 GF Score
Price €0.14
! 2 Warning Signs
View Full Analysis

What is Izotropic Research & Development?

Izotropic FRA:1R3 28 Research & Development is €0.48 Mil as of Jan. 2026. GuruFocus rates FRA:1R3 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Izotropic's Research & Development for the three months ended in Jan. 2026 was €0.12 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was €0.48 Mil.

Izotropic  (FRA:1R3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Izotropic Research & Development Related Terms

Izotropic Research & Development Historical Data

* Premium members only.

The historical data trend for Izotropic's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Izotropic Research & Development Chart

Izotropic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.53 2.54 1.62 0.54 0.43

Izotropic Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.11 0.09 0.16 0.12
FRA:1R3
28GF Score
Izotropic Corp FRA:1R3
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Izotropic Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.48 Mil mean?
Izotropic (FRA:1R3) has a Research & Development of €0.48 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on Izotropic and its competitors.
Is Izotropic's Research & Development too high?
Izotropic's current Research & Development is €0.48 Mil. Overall, Izotropic has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Izotropic's Research & Development compare to TMO and DHR?
Izotropic's Research & Development of €0.48 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Izotropic and its competitors. Izotropic's current Research & Development is €0.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Izotropic stock overvalued right now?
Izotropic (FRA:1R3) has a current Research & Development of €0.48 Mil. The current Research & Development is €0.48 Mil. Izotropic's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Izotropic (FRA:1R3), the current Research & Development is €0.48 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Izotropic Business Description

Address 800 - 15355 24th Avenue, Suite 424, Surrey, BC, CAN, V4A 2H9
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
28GF Score

Get the complete analysis for FRA:1R3

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price